BMY Oct 2024 46.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:58PM EDT. Market open.
Loading interactive chart…
- Business Wire
Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or Sorafenib as First-Line Treatment for Patients with Advanced Hepatocellular Carcinoma in CheckMate -9DW Trial
PRINCETON, N.J., June 04, 2024--Bristol Myers Squibb Announces Opdivo (nivolumab) Plus Yervoy (ipilimumab) Significantly Improved Overall Survival Compared to Lenvatinib or....
- Simply Wall St.
Shareholders in Bristol-Myers Squibb (NYSE:BMY) are in the red if they invested a year ago
The simplest way to benefit from a rising market is to buy an index fund. But if you buy individual stocks, you can do...
- Business Wire
Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
PRINCETON, N.J., June 04, 2024--Bristol Myers Squibb to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
© 2024 Yahoo. All rights reserved.